Aug 6, 2026 04:05PM
Jul 22, 2026 03:23AM
Jun 12, 2026 12:45PM
Jun 12, 2026 12:45PM
Jun 8, 2026 06:00AM
Jun 8, 2026 06:00AM
May 6, 2026 04:05PM Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
Mar 12, 2026 04:05PM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Dec 24, 2025 06:00AM
Dec 24, 2025 06:00AM
Dec 8, 2025 02:52AM
Dec 7, 2025 04:30PM Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and
Nov 12, 2025 04:05PM
Nov 10, 2025 07:30AM
Nov 10, 2025 07:30AM
Nov 3, 2025 09:00AM
Nov 3, 2025 09:00AM
Sep 3, 2025 08:00AM
Sep 3, 2025 08:00AM Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
Aug 12, 2025 04:05PM
Jun 24, 2025 06:48AM
Jun 23, 2025 05:00PM
Jun 17, 2025 06:31AM
Jun 17, 2025 06:30AM
May 13, 2025 04:05PM
May 1, 2025 09:00AM Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma
Apr 15, 2025 09:00AM
Apr 15, 2025 09:00AM
Mar 11, 2025 04:05PM
Jan 9, 2025 09:00AM
Dec 9, 2024 09:00PM
Nov 7, 2024 04:05PM
Nov 5, 2024 09:30AM Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
Oct 24, 2024 04:00PM
Oct 24, 2024 04:00PM
Aug 7, 2024 04:05PM
Jun 26, 2024 07:02AM
Jun 26, 2024 07:00AM
Feb 28, 2024 04:05PM
Nov 9, 2023 04:05PM Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
Nov 8, 2022 04:05PM
Nov 8, 2022 04:05PM
Oct 6, 2022 04:05PM
Oct 6, 2022 04:05PM
Oct 6, 2022 04:05PM
May 10, 2022 04:05PM
May 10, 2022 04:05PM Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
Mar 29, 2022 04:05PM

329,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All